87—Schedule of ratings–ear 87 87 Schedule of ratings—ear. Diseases of the Ear

4.87- §4.87—Schedule of ratings–ear 4.87-

§4.87 Schedule of ratings—ear.

Diseases of the Ear

Rating
6200 Chronic suppurative otitis media, mastoiditis, or cholesteatoma

(or any combination):
During suppuration, or with aural polyps 10
Note: Evaluate hearing impairment, and complications such as labyrinthitis, tinnitus, facial nerve paralysis, or bone loss of skull, separately.
6201 Chronic nonsuppurative otitis media with effusion (serous otitis media):
Rate hearing impairment
6202 Otosclerosis:
Rate hearing impairment
6204 Peripheral vestibular disorders:
Dizziness and occasional staggering 30

Occasional dizziness 10

Note: Objective findings supporting the diagnosis of vestibular disequilibrium are required before a compensable evaluation can be assigned under this code. Hearing impairment or suppuration shall be separately rated and combined.
6205 Meniere’s syndrome (endolymphatic hydrops):
Hearing impairment with attacks of vertigo and cerebellar gait

occurring more than once weekly, with or without tinnitus 100

Hearing impairment with attacks of vertigo and cerebellar gait

occurring from one to four times a month, with or without tinnitus 60

Hearing impairment with vertigo less than once a month, with or

without tinnitus 30

Note: Evaluate Meniere’s syndrome either under these criteria or by separately evaluating vertigo (as a peripheral vestibular disorder), hearing impairment, and tinnitus, whichever method results in a higher overall evaluation. But do not combine an evaluation for hearing impairment, tinnitus, or vertigo with an evaluation under diagnostic code 6205.
6207 Loss of auricle:
Complete loss of both 50

Complete loss of one 30

Deformity of one, with loss of one-third or more of the substance 10

6208 Malignant neoplasm of the ear (other than skin only) 100
Note: A rating of 100 percent shall continue beyond the cessation of any surgical, radiation treatment, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based on that or any subsequent examination shall be subject to the provisions of §3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residuals.
6209 Benign neoplasms of the ear (other than skin only):
Rate on impairment of function.
6210 Chronic otitis externa:
Swelling, dry and scaly or serous discharge, and itching

requiring frequent and prolonged treatment 10

6211 Tympanic membrane, perforation of 0
6260 Tinnitus, recurrent 10
Note (1): A separate evaluation for tinnitus may be combined with an evaluation under diagnostic codes 6100, 6200, 6204, or other diagnostic code, except when tinnitus supports an evaluation under one of those diagnostic codes.
Note (2): Assign only a single evaluation for recurrent tinnitus, whether the sound is perceived in one ear, both ears, or in the head.
Note (3): Do not evaluate objective tinnitus (in which the sound is audible to other people and has a definable cause that may or may not be pathologic) under this diagnostic code, but evaluate it as part of any underlying condition causing it.
(Authority: 38 U.S.C. 1155).

[29 FR 6718, May 22, 1964, as amended at 64 FR 25209, May 11, 1999; 68 FR 25823, May 14, 2003]

Supplement Highlights references: 25(1), 32(1).

Next Section is §4.87a

(No. 32 5/25/03)